Jiangsu Bioperfectus Technologies Co.,Ltd. (688399.SH) announced that the company has recently received medical device registration certificates (in vitro diagnostic reagents) issued by the National Medical Products Administration. The approved products include the Adenovirus Antigen Detection Kit (Colloidal Gold Method) and the Seven Respiratory Pathogen Nucleic Acid Detection Kit (Fluorescent PCR Method). The acquisition of these Medical Device Registration Certificates enriches the company's product portfolio, expands its presence in the in vitro diagnostics sector, and continuously meets diversified clinical demands. This development will strengthen the company's comprehensive competitiveness and facilitate further enhancement of its market expansion capabilities.